This study demonstrated that ACSL4 correlated significantly with the recruitment of immune cells, including critical CD8+ T cells, in the BLCA microenvironment, which may have prevented tumor invasion and improved survival outcomes for BLCA patients. The gene discussed is ACSL4; the disease is bladder transitional cell carcinoma.